Search

Search any products, services and so on here.

About 21739 result(s)

Global Biktarvy Market Research Report 2025

  • May 05, 25
  • ID: 207379
  • Pages: 87
  • Figures: 81
  • Views: 53
  • From $2,900

The global market for Biktarvy was valued at US$ 15760 million in the year 2024 and is projected to reach a revised size of US$ 19070 million by 2031, growing at a CAGR of 2.7% during the forecast period. Biktarvy (Chinese trade name: Bituowei) is a fixed-dose combination antiretroviral drug used to treat human immunodeficiency virus type 1 (HIV-1) infection. It consists of three active ingredient...


Global Dupilumab Drug Market Research Report 2025

  • May 05, 25
  • ID: 207381
  • Pages: 76
  • Figures: 71
  • Views: 43
  • From $2,900

The global market for Dupilumab Drug was valued at US$ 18570 million in the year 2024 and is projected to reach a revised size of US$ 36530 million by 2031, growing at a CAGR of 10.3% during the forecast period. Dupilumab is a fully human monoclonal antibody used to treat a range of chronic inflammatory conditions driven by type 2 inflammation, such as moderate-to-severe atopic dermatitis, asthma,...


Global Elasomeran Market Research Report 2025

  • May 05, 25
  • ID: 216499
  • Pages: 74
  • Figures: 67
  • Views: 48
  • From $2,900

The global market for Elasomeran was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 339 million by 2031, growing at a CAGR of -2.2% during the forecast period. Elasomeran is an mRNA vaccine developed collaboratively by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna Inc., primarily designed to prevent COVID-19 infection. The...


Global Coronary Artery Bypass Grafts (CABG) Market Research Report 2025

  • Apr 23, 25
  • ID: 214367
  • Pages: 76
  • Figures: 79
  • Views: 206
  • From $2,900

The global market for Coronary Artery Bypass Grafts (CABG) was valued at US$ 142 million in the year 2024 and is projected to reach a revised size of US$ 202 million by 2031, growing at a CAGR of 5.2% during the forecast period. Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to rest...


Global Diagnostic Reagent Market Research Report 2025

  • Apr 23, 25
  • ID: 214374
  • Pages: 91
  • Figures: 95
  • Views: 64
  • From $2,900

The global market for Diagnostic Reagent was valued at US$ 69630 million in the year 2024 and is projected to reach a revised size of US$ 92500 million by 2031, growing at a CAGR of 4.2% during the forecast period. Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue. Global Diagnostic Reagent key players...


Global Marine Derived Drugs Market Research Report 2025

  • Apr 23, 25
  • ID: 214231
  • Pages: 85
  • Figures: 87
  • Views: 282
  • From $2,900

The global market for Marine Derived Drugs was valued at US$ 2770 million in the year 2024 and is projected to reach a revised size of US$ 4959 million by 2031, growing at a CAGR of 8.8% during the forecast period. Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous inf...


Global Cannabidiol (CBD) Market Research Report 2025

  • Apr 23, 25
  • ID: 214276
  • Pages: 88
  • Figures: 89
  • Views: 206
  • From $2,900

The global market for Cannabidiol (CBD) was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 1010 million by 2031, growing at a CAGR of 13.9% during the forecast period. Global key players of Cannabidiol (CBD) include Aurora Cannabis, Charlotte's Web CBD, Endoca, Kazmira, KND Labs, etc. The top five players hold a share about 19%. North America is the larg...


Global Docetaxel Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • Apr 23, 25
  • ID: 214130
  • Pages: 71
  • Figures: 70
  • Views: 66
  • From $4,250

The global Docetaxel market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or alo...


Global Renin-Inhibitors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • Apr 23, 25
  • ID: 214181
  • Pages: 67
  • Figures: 67
  • Views: 208
  • From $4,250

The global Renin-Inhibitors market size was US$ 104 million in 2024 and is forecast to a readjusted size of US$ 163 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031. Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for s...


Global Tylosin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • Apr 23, 25
  • ID: 213999
  • Pages: 80
  • Figures: 76
  • Views: 59
  • From $4,250

The global Tylosin market size was US$ 1192 million in 2024 and is forecast to a readjusted size of US$ 1624 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031. Global core Tylosin manufacturers include Elanco, Huvepharma, Shandong Lukang Pharmaceutical, Ningxia Tairui Pharmaceutical, Qilu Pharmaceutical Group and Wuhan HVSEN Biotechnology. Asia Pacific is the world's larges...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232